Top Tweets for #InVivoModels
⚗️Workshop: Harmonizing In Vivo Models of Immunotherapy was a great success!
Great energy and thoughtful discussion at the Workshop in Bergen, where 53 participants explored how #invivomodels can drive progress in #immunotherapy.
👏 Huge thanks to organizers
#COST

📌#antioxidant #bioactivecompounds #secondarymetabolites #antioxidantassay #invitromodels #invivomodels
New Publication “Natural Antioxidant Evaluation: A Review of Detection Methods”
By: Valter Aragão do Nascimento, et al.
👉https://t.co/MTIkRsfhPF
#mdpimolecules #NewPublication

#canSERV_EU partner presentation #10: @InfrafrontierEU - European #ResearchInfrastructure for #DiseaseModels! 👋
It offers various services for #CancerResearchers & leads the efforts concerning #InVivoModels in canSERV.
#GeneticAlterations #GeneFunction
https://t.co/ZcxPB4DEHe

🤔Why we cannot cure #pancreaticcancer?still the absence of feasible #experimentalmodels❗️
This new paper describes how to creat efficient 🐭 models by system for temporal and regulatable in vivo cytosine base editing (#iBE)
#PDAC
#invivomodels

This month, we focus on #DrugResistance for our #InVivoModels spotlight. Our first feature is the EGFR TKI resistant NSCLC CDX model HCC827-ER1.
✅Clinically relevant EGFR exon 19 deletion
✅Increased c-MET copy number
✅Combination Therapy data available
Learn more⬇️
This month, we focus on #DrugResistance for our #InVivoModels spotlight. Our first feature is the erlotinib-resistant NSCLC CDX model HCC827-ER1.
✅Clinically relevant EGFR exon 19 deletion
✅Increased c-MET copy number
✅Combination Therapy data available
Learn more⬇️

We're featuring 3️⃣ #BloodCancer models for our #InVivoModels spotlight this month.
The first is a Patient Derived Xenograft #AcuteMyeloidLeukemia model AM7577.
Learn more about AM7577 and our unique collection of AML and ALL PDX models.
#PreclinicalResearch #Oncology ⬇️

After the Poster viewing at 9:30 today is my talk at #SASMetastasis19 on immune evasion and #metastasis in #colorectalcancer. #InVivoModels #Metastasis @EACRnews

Thank you to our #SASMetastasis19 exhibitors @10xGenomics @ecticatech & @VectorBuilder. See them on stage at the Exhibitor Introductions at 16:10! #InVivoModels #Metastasis #InVivoModels https://t.co/uK1O5W0PFN

We are really looking forward to welcoming all of our participants to the 2nd joint EACR-MRS Conference on #SeedAndSoil in Berlin! Registration opens at 1pm with the Conference Welcome at 14;30! #SASMetastasis19 #InVivoModels @MetastasisRS

⚠️📢 Attention! 📢⚠️
It's the registration deadline for our #SeedAndSoil conference in Berlin, Germany, TOMORROW on 6 September 2019! #SASMetastasis19 #InVivoModels #Metastasis
Register here: https://t.co/AyZ9rQLp8i

📢📢 Attention! 📢📢
There are TWO weeks until the registration deadline for the 2nd joint EACR-@MetastasisRS Conference on Seed and Soil: Mechanisms of Metastasis! The deadline is Friday 6 September 2019.
#SASMetastasis19 #InVivoModels
Register here: https://t.co/AyZ9rQLp8i

⚠️It's the Abstract and Bursary deadline TOMORROW 31st July⚠️ for our Seed and Soil: Mechanisms of Metastasis conference in Berlin this October!
#InVivoModels
#Metastasis
https://t.co/AyZ9rQLp8i

📢 Topics to be covered in our Seed and Soil conference include (epi)genetic, signaling, immune, microenvironment & metabolic aspects of:
* #Metastasis Initiation
* Metastasis Formation & Maintenance
* Targeting Metastasis 📢
#SASMetastasis19 #InVivoModels
https://t.co/38oH0mP2Ta

100% of participants from our previous Seed and Soil conference would recommend it to others, and 97% were satisfied with the networking opportunities!
#SASMetastasis19 #InVivoModels #Metastasis
https://t.co/k0iOaz6Qec

Just some of the great feedback from the previous conference:
“The quality of the lectures was excellent, the speakers remained until the end of the meeting and were very open to speak with the participants...”
#SASMetastasis19 #InVivoModels #Metastasis
https://t.co/k0iOaz6Qec

Topics that will be explored in the Seed and Soil 2019 Conference:
(Epi)genetic, signaling, immune, microenvironment and metabolic aspects of:
- Metastasis Initiation
- Metastasis Formation
-Maintenance and Targeting Metastasis
#SASMetastasis19 #InVivoModels #Metastasis

🇩🇪🗣️ We have great speakers attending the Seed and Soil 2019 conference including Andreas Trumpp, Patricia Steeg, Cedric Blanpain, Caroline Dive and many more! Click here to find out more: https://t.co/k0iOaz6Qec #SASMetastasis19 #InVivoModels #Metastasis

Always a pleasure to visit EU #skelGEN collaborator Prof Richard Oreffo; Jon Dawson and give seminar to #BoneandJoint Gp @unisouthampton; discussing #bioinks #invivomodels for #boneregeneration AND #angiogenesis @Khoonono

Andreas Trumpp gives the last keynote lecture of #SAS17: "Cellular and Molecular Deconvolution of Human Pancreatic and Breast Cancers" #InVivoModels #Metastasis @MetastasisRS https://t.co/qLzwOocnju
Last Seen Hashtags on Sotwe
castfetish
Seen from Turkey
pecanberrysalad
Seen from United States
Velder
Seen from United States
CaughtOnCamera
Seen from Canada
Master
Seen from United Kingdom
kayseri
Seen from Turkey
สาวสองรับงานเชียงใหม่
Seen from United States
robloxcondo
Seen from Malaysia
SusuzYaz
Seen from Turkey
mgai(*****************************)filter:videos
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.5M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers













